VITAmin and Micronutrient Testing: Acceptability and SCOPE of Point-of-care Device
Launched by NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Mar 12, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Malnutrition, where there is an insufficient supply or inability to absorb nutrients is classified by the World Health Organisation as the biggest worldwide threat to public health. Untreated malnutrition is an independent risk factor for mortality and is associated with increased healthcare costs. Malnutrition is not only found in association with low weight but is also found in individuals with morbid obesity. Obese individuals experience a state of paradoxical malnutrition; despite excessive dietary intake they have high micronutrient deficiencies rates due to intake of energy-dense, nut...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged\>10 years or parents of a patient being seen in a NNUH CEW clinic.
- • Parents/Participants must have capacity to consent/assent and provide a signed and dated informed consent
- • Able to participate in an interview regarding the acceptability/usability of the device.
- Exclusion criteria:
- • - Potential participants will not be eligible if they lack capacity to provide informed consent (or in the case of young people under the age of 16, informed assent and informed parental consent)
About Norfolk And Norwich University Hospitals Nhs Foundation Trust
Norfolk and Norwich University Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering exceptional patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust facilitates innovative research initiatives aimed at improving treatment outcomes and enhancing patient well-being. With a commitment to high ethical standards and collaboration with various stakeholders, the Trust plays a pivotal role in driving forward the development of new therapies and interventions across diverse medical fields. Its multidisciplinary approach and state-of-the-art facilities ensure a robust framework for conducting clinical trials that contribute to evidence-based medicine and the advancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norwich, Norfolk, United Kingdom
Patients applied
Trial Officials
Emma Webb, PhD
Principal Investigator
Consultant at NNUH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported